Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model

被引:5
|
作者
Porath, Binu [1 ]
Livingston, Safia [2 ]
Andres, Erica L. [2 ]
Petrie, Alexandra M. [2 ]
Wright, Joshua C. [2 ]
Woo, Anna E. [3 ]
Carlton, Carol G. [4 ]
Baybutt, Richard [5 ]
Vanden Heuvel, Gregory B. [2 ,6 ]
机构
[1] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA
[2] Wheaton Coll, Dept Biol, Wheaton, IL 60187 USA
[3] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA
[4] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS USA
[5] Wheaton Coll, Dept Appl Hlth Sci, Wheaton, IL 60187 USA
[6] Western Michigan Univ, Dept Biomed Sci, Homer Stryker MD Sch Med, 1000 Oakland Dr, Kalamazoo, MI 49008 USA
关键词
Cux1; polycystic kidney disease; p27; HOMEODOMAIN PROTEIN CUX1; CYST FORMATION; MICE LACKING; CUT HOMEODOMAIN; MULTIORGAN HYPERPLASIA; P27(KIP1) EXPRESSION; DOWN-REGULATION; CPK MICE; GROWTH; PKD1;
D O I
10.1152/ajprenal.00380.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common monogenic hereditary disorders in humans characterized by fluid-filled cysts, primarily in the kidneys. Cux1, a cell cycle regulatory gene highly expressed during kidney development, is elevated in the cyst-lining cells of Pkd1 mutant mice, and in human ADPKD cells. However, forced expression of Cux1 is insufficient to induce cystic disease in transgenic mice or to induce rapid cyst formation after cilia disruption in the kidneys of adult mice. Here we report a double mutant mouse model that has a conditional deletion of the Pkd1 gene in the renal collecting ducts together with a targeted mutation in the Cux1 gene (Pkd1(CD); Cux1(tm2Ejn)). While kidneys isolated from newborn Pkd1(CD) mice exhibit cortical and medullary cysts, kidneys isolated from newborn Pkd1CD; Cux1(tm2Ejn-/-) mice did not show any cysts. Because Cux1(tm2Ejn-/-) are perinatal lethal, we evaluated Pkd1(CD) mice that were heterozygote for the Cux1 mutation. Similar to the newborn Pkd1CD; Cux1(tm2Ejn-/-) mice, newborn Pkd1(CD); Cux1(tm2Ejn-/-) mice did not show any cysts. Comparison of Pkd1(CD) and Pkd1(CD); Cux1(tm2Ejn-/-) mice at later stages of development showed a reduction in the severity of PKD in the Pkd1(CD); Cux1(tm2Ejn-/-) mice. Moreover, we observed an increase in expression of the cyclin kinase inhibitor p27, a target of Cux1 repression, in the rescued collecting ducts. Taken together, our results suggest that Cux1 expression in PKD is not directly involved in cystogenesis but promotes cell proliferation required for expansion of existing cysts, primarily by repression of p27.
引用
收藏
页码:F1050 / F1059
页数:10
相关论文
共 50 条
  • [31] Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease
    Cassini, Marcelo F.
    Kakade, Vijayakumar R.
    Kurtz, Elizabeth
    Sulkowski, Parker
    Glazer, Peter
    Torres, Richard
    Somlo, Stefan
    Cantley, Lloyd G.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (10): : 2471 - 2481
  • [32] Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease
    Nielsen, Marlene L.
    Mundt, Mia C.
    Lildballe, Dorte L.
    Rasmussen, Maria
    Sunde, Lone
    Torres, Vicente E.
    Harris, Peter C.
    Birn, Henrik
    CLINICAL KIDNEY JOURNAL, 2021, 14 (11) : 2420 - 2427
  • [33] Comparison of folate-conjugated rapamycin versus unconjugated rapamycin in an orthologous mouse model of polycystic kidney disease
    Kipp, Kevin R.
    Kruger, Samantha L.
    Schimmel, Margaret F.
    Parker, Nikki
    Shillingford, Jonathan M.
    Leamon, Christopher P.
    Weimbs, Thomas
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2018, 315 (02) : F395 - F405
  • [34] A chalcone derivative retards renal cyst enlargement by inhibiting fluid secretion and cell proliferation in an in vitro model of polycystic kidney disease
    Veeraphan, Peerachat
    Chavasiri, Warinthorn
    Muanprasat, Chatchai
    Chatsudthipong, Varanuj
    Yuajit, Chaowalit
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (09) : 944 - 952
  • [35] Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion
    Nantavishit, Jiriporn
    Chatsudthipong, Varanuj
    Soodvilai, Sunhapas
    BIOCHEMICAL PHARMACOLOGY, 2018, 154 : 175 - 182
  • [36] ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease
    Gooz, Monika Beck
    Maldonado, Eduardo N.
    Dang, Yujing
    Amria, May Y.
    Higashiyama, Shigeki
    Abboud, Hanna E.
    Lemasters, John J.
    Bell, P. Darwin
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 307 (05) : F551 - F559
  • [37] Assessment of photoacoustic computed tomography to classify tissue in a polycystic-kidney disease mouse model
    Liu, Bo
    Gattone, Vincent H., II
    Kruger, Robert A.
    Stantz, Keith M.
    PHOTONS PLUS ULTRASOUND: IMAGING AND SENSING 2006, 2006, 6086
  • [38] A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation
    Woollard, J. R.
    Punyashtiti, R.
    Richardson, S.
    Masyuk, T. V.
    Whelan, S.
    Huang, B. Q.
    Lager, D. J.
    vanDeursen, J.
    Torres, V. E.
    Gattone, V. H.
    LaRusso, N. F.
    Harris, P. C.
    Ward, C. J.
    KIDNEY INTERNATIONAL, 2007, 72 (03) : 328 - 336
  • [39] Network Analysis of a Pkd1-Mouse Model of Autosomal Dominant Polycystic Kidney Disease Identifies HNF4α as a Disease Modifier
    Menezes, Luis F.
    Zhou, Fang
    Patterson, Andrew D.
    Piontek, Klaus B.
    Krausz, Kristopher W.
    Gonzalez, Frank J.
    Germino, Gregory G.
    PLOS GENETICS, 2012, 8 (11):
  • [40] Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease
    Leonhard, Wouter N.
    Song, Xuewen
    Kanhai, Anish A.
    Iliuta, Ioan-Andrei
    Bozovic, Andrea
    Steinberg, Gregory R.
    Peters, Dorien J. M.
    Pei, York
    EBIOMEDICINE, 2019, 47 : 436 - 445